Want to see JP:6092 full AI Analyst Report?
EnBio Holdings, Inc. (6092) Stock Price & Analysis
6092 Stock Chart & Stats
- Day’s Range
- JPY 765.00 - JPY 790.00
- 52-Week Range
- JPY 559.00 - JPY 1,009.00
- Previous Close
- JPY 784.00
- Volume
- N/A
- Average Volume (3M)
- 16.19K
- Market Cap
- JPY 6.24B
- Enterprise Value
- JPY 12.54B
- Total Cash (Recent Filing)
- JPY 4.04B
- Total Debt (Recent Filing)
- JPY 10.65B
- Price to Earnings (P/E)
- 11.2
- Beta
- 0.38
- Next Earnings
- Nov 18, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Mar 30, 2027
- Dividend Yield
- 1.18%
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth
Rapid revenue expansion indicates solid demand momentum and continued business activity. If sustained, this growth can broaden the company’s operating base, support reinvestment, and provide a foundation for improved earnings leverage even though current profitability remains weak.
Operating Cash Flow Rebound
The sharp recovery in operating cash flow shows that the business can generate substantially more internal liquidity when conditions improve. This supports funding of operations and investment, although the benefit is tempered by still-thin free cash flow and recent volatility.
Expanding Asset And Equity Base
Growth in equity and assets alongside higher revenue suggests the company has expanded its resource base with its business activity. This provides a broader platform for future operations and investment, while the relatively larger equity base offers some support against financial pressure.
Bears Say
Profitability Compression
Material margin compression means substantially less profit is being generated from each unit of revenue. Net income also declined despite higher sales, indicating that stronger growth is not currently translating into dependable earnings and could constrain reinvestment capacity.
Elevated Leverage
Debt exceeding equity increases financial risk while returns remain weak, because interest and repayment obligations can absorb cash that might otherwise support growth. Elevated leverage also reduces flexibility if profitability stays pressured or operating conditions deteriorate.
Volatile Free Cash Flow
Thin and inconsistent free cash flow weakens the quality of reported earnings and makes internal funding less predictable. The sharp swing from cash burn to limited positive generation suggests working-capital or investment demands can materially affect liquidity and capital allocation.
EnBio Holdings, Inc. News
6092 FAQ
What was EnBio Holdings, Inc.’s price range in the past 12 months?
What is EnBio Holdings, Inc.’s market cap?
When is EnBio Holdings, Inc.’s upcoming earnings report date?
How were EnBio Holdings, Inc.’s earnings last quarter?
Is EnBio Holdings, Inc. overvalued?
Does EnBio Holdings, Inc. pay dividends?
What is EnBio Holdings, Inc.’s EPS estimate?
How many shares outstanding does EnBio Holdings, Inc. have?
What happened to EnBio Holdings, Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of EnBio Holdings, Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
EnBio Holdings, Inc.
EnBio Holdings, Inc. engages in the provision of soil pollution countermeasure services. It operates through the following segments: Soil Pollution Countermeasures, Brownfield Utilization, and Natural Energy. The Soil Pollution Countermeasures segment offers risk consulting services including investigation and construction of countermeasures for soil pollution. It also imports and sells equipment and purifying chemicals used for in situ investigation and purification. The Brownfield Utilization segment manages the buying, restoration, and reselling of contaminated lands. The Natural Energy segment handles the sale of power from natural energy. The company was founded on June 23, 1999 and is headquartered in Tokyo, Japan.
- Sector
- Industrials
- Industry
- Environmental Services
- CEO
- Ryosuke Mori
- Employees
- 113
- Website
- enbio-holdings.com
- Address
- Kanda Park Plaza, Tokyo, TY, 101-0044, JP
EnBio Holdings, Inc. (6092) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 5 | 12 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 2 | 0 | 10 |






